Evidence map›Paper›PMID 36325468›Full record

Trial reportFrontiers in cellular and infection microbiology2022

Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19.

Jing Zhang, Hongguang Sheng, Xiaoyi Tang, Panpan Xia, Zhangwang Li, Minxuan Xu, Jianyong Ma, Yunfeng Shen, Peng Yu, Xiao Liu

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jing ZhangDepartment of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Hongguang ShengDepartment of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiaoyi TangDepartment of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Panpan XiaDepartment of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhangwang LiThe Second Clinical Medical College of Nanchang University, Nanchang, China.
Minxuan XuDepartment of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jianyong MaDepartment of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Yunfeng ShenDepartment of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Peng YuDepartment of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiao LiuInstitute for the Study of Endocrinology and Metabolism in Jiangxi Province, Nanchang, China.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CNUniversity of Cincinnati Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with coronavirus disease 2019 (COVID-19) has raised great concerns. The effect of NSAIDs on the clinical status of COVID-19 remains in question. Therefore, we performed a

Indexed as

COVID-19 Drug TreatmentAdultAnti-Inflammatory Agents, Non-SteroidalHospitalizationHumansMeta-Analysis as TopicPandemicsAnti-Inflammatory Agents, Non-SteroidalCOVID-19dischargemortalitynonsteroidal anti-inflammatory drugsseverity

Identifiers

PMID36325468
PMCPMC9618688
OpenAlexW4306381770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.